BNP Paribas Arbitrage SA raised its position in shares of Proto Labs, Inc. (NYSE:PRLB) by 67.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,995 shares of the industrial products company’s stock after acquiring an additional 5,249 shares during the period. BNP Paribas Arbitrage SA’s holdings in Proto Labs were worth $1,043,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of PRLB. Teachers Advisors LLC raised its holdings in shares of Proto Labs by 3.7% during the 1st quarter. Teachers Advisors LLC now owns 44,891 shares of the industrial products company’s stock worth $2,294,000 after acquiring an additional 1,607 shares in the last quarter. California Public Employees Retirement System purchased a new stake in shares of Proto Labs during the 1st quarter worth approximately $230,000. Dimensional Fund Advisors LP raised its holdings in shares of Proto Labs by 14.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 351,431 shares of the industrial products company’s stock worth $17,958,000 after acquiring an additional 44,535 shares in the last quarter. UBS Group AG raised its holdings in shares of Proto Labs by 128.0% during the 1st quarter. UBS Group AG now owns 2,603 shares of the industrial products company’s stock worth $133,000 after acquiring an additional 11,895 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. raised its holdings in shares of Proto Labs by 4.4% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 104,131 shares of the industrial products company’s stock worth $5,322,000 after acquiring an additional 4,342 shares in the last quarter.

Several equities analysts have recently weighed in on the company. Craig Hallum set a $92.00 target price on Proto Labs and gave the company a “hold” rating in a research report on Monday. Zacks Investment Research raised Proto Labs from a “hold” rating to a “buy” rating and set a $96.00 target price on the stock in a research report on Friday, November 3rd. Finally, BidaskClub downgraded Proto Labs from a “strong-buy” rating to a “buy” rating in a research report on Friday, October 6th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $75.00.

Proto Labs, Inc. (NYSE:PRLB) traded down $1.70 during midday trading on Friday, hitting $94.50. The stock had a trading volume of 143,480 shares, compared to its average volume of 193,027. The company has a market cap of $2,542.01, a P/E ratio of 54.51, a P/E/G ratio of 2.39 and a beta of 1.03. Proto Labs, Inc. has a 52-week low of $48.00 and a 52-week high of $96.95.

Proto Labs (NYSE:PRLB) last released its earnings results on Thursday, October 26th. The industrial products company reported $0.56 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.04. The firm had revenue of $88.10 million for the quarter, compared to the consensus estimate of $85.68 million. Proto Labs had a return on equity of 11.63% and a net margin of 14.53%. The company’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.51 EPS. equities analysts forecast that Proto Labs, Inc. will post 1.9 earnings per share for the current fiscal year.

In other Proto Labs news, VP John B. Tumelty sold 13,556 shares of the company’s stock in a transaction on Wednesday, November 22nd. The stock was sold at an average price of $92.07, for a total value of $1,248,100.92. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Rainer Gawlick sold 1,500 shares of the company’s stock in a transaction on Tuesday, November 21st. The shares were sold at an average price of $90.31, for a total value of $135,465.00. Following the completion of the transaction, the director now directly owns 6,925 shares in the company, valued at approximately $625,396.75. The disclosure for this sale can be found here. Insiders own 7.78% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was reported by Watch List News and is the sole property of of Watch List News. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at https://www.watchlistnews.com/bnp-paribas-arbitrage-sa-purchases-5249-shares-of-proto-labs-inc-prlb/1737858.html.

Proto Labs Company Profile

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB).

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.